Cefdinir

Product NDC: 50090-6171
11-digit product format: 500906171
Labeler code: 50090
Product ID: 50090-6171_07cacf06-d973-4928-b449-e3b8d1eee34a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA065259
Marketing category: ANDA
Marketing start: 2007-05-07
Substance: CEFDINIR
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065259-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2006-05-31
A065259-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065259-001	AB
A065259-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065259-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065259-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065259-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065259-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065259-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065259-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065259-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065259-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065259-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065259-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065259-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065259-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065259-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065259-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065259-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065259-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065259-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065259-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefdinir
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFDINIR	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
CI0FAO63WC	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
476576	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
37b5d000-db9e-4b6e-8208-6361e98fb55d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
d3e72f63-2c41-955f-f4ce-e90c6403e67c	Product name	2	20210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1	Product name	2	20210729
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-6171-0	Cefdinir	60 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	60		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-6171-0	ML - Milliliter	50090-6171	3d5cb751-9dd0-405f-a6c3-ff62b5d20a2a	1	2022-12-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-6171	CEFDINIR POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS]	3	Current NDC, Legacy NDC, 1 package rows	20231102_37b5d000-db9e-4b6e-8208-6361e98fb55d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	3714d558-cbaa-42e8-831b-ffbbc951ebf2	2026-04-21	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	A-S Medication Solutions	17b4e82f-4169-4ab9-bd4a-79781a71e160	2025-12-19	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	Lupin Pharmaceuticals, Inc.	7490df67-56c0-4a1c-8533-2107f3e8aea5	2025-09-23	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	Asclemed USA, Inc.	e90660c8-2714-4592-aeaa-bc9ceb26057c	2025-04-19	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals, Inc.	2fb43fbe-2c4b-1df9-e063-6394a90a9913	2025-03-06	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	fbd76f8c-e6b8-52f4-e053-6394a90aa7ab	2025-02-04	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
CEFDINIR	CEFDINIR	DIRECT RX	982d0f53-20bc-1cb4-e053-2995a90ad33c	2025-01-22	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	1bbd75ea-5a50-eb00-e063-6394a90a1cec	2024-06-25	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	A-S Medication Solutions	37b5d000-db9e-4b6e-8208-6361e98fb55d	2023-11-01	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259 ndc (product): 50090-6171
Cefdinir	CEFDINIR	Proficient Rx LP	444cd2c4-836d-40d5-a307-d719fe83e763	2022-05-02	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CI0FAO63WC	CEFDINIR	91832-40-5	CEFDINIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
476576	cefdinir 250 MG in 5 mL Oral Suspension	PSN	37b5d000-db9e-4b6e-8208-6361e98fb55d	3
476576	cefdinir 50 MG/ML Oral Suspension	SCD	37b5d000-db9e-4b6e-8208-6361e98fb55d	3
476576	cefdinir 250 MG per 5 ML Oral Suspension	SY	37b5d000-db9e-4b6e-8208-6361e98fb55d	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-6171-0	50090617100	60 mL in 1 BOTTLE (50090-6171-0)	60 ml	2022-10-14	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir for Oral Suspension USP	A-S Medication Solutions	2023-11-01	HUMAN PRESCRIPTION DRUG LABEL	3